Compound 1385
Identifiers
- Canonical SMILES:
CC(C)CC[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C
- IUPAC name:
(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N,N-dimethyl-5'-(3-methylbutyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C25H29Cl2N3O2/c1-14(2)8-11-20-25(18-10-9-17(27)13-19(18)28-24(25)32)21(15-6-5-7-16(26)12-15)22(29-20)23(31)30(3)4/h5-7,9-10,12-14,20-22,29H,8,11H2,1-4H3,(H,28,32)/t20-,21+,22-,25+/m1/s1
- InChiKey:
OASBUJMRXJSSMB-FFHOAYQKSA-N
External links
![]() 11431434 |
![]() 9606309 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 3 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.41 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 473.16 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 4.89 | |||
TPSA | 61.44 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 3 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
16028899 | 1f | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.41 | |
16028899 | 1f | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | LNCaP cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.72 |
16028899 | 1f | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | PC-3 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.46 |
16028899 | 1f | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | PrEC cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.70 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8415 | SAR-405838 | DB12541 | |
0.6618 | Milademetan | DB15257 | |
0.5758 | Mosapramine | DB13676 | |
0.5616 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07090 | |
0.5616 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07222 | |
0.5476 | OPC-51803 | DB05838 | |
0.5473 | 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone | DB02058 | |
0.5460 | SLV-334 | DB15356 | |
0.5411 | Amedalin | DB09188 | |
0.5346 | Degarelix | DB06699 | |
0.5322 | OPC-14523 | DB05422 | |
0.5278 | Daglutril | DB05796 | |
0.5220 | Idasanutlin | DB12325 | |
0.5208 | Lorcainide | DB13653 | |
0.5179 | Benazeprilat | DB14125 |